A Case of Acute Cholestatic Hepatitis Associated with Orlistat / 대한간학회지
The Korean Journal of Hepatology
;
: 317-320, 2002.
Artigo
em Coreano
| WPRIM
| ID: wpr-117146
ABSTRACT
Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Resumo em Inglês
/
Colestase
/
Doença Aguda
/
Fármacos Antiobesidade
/
Doença Hepática Induzida por Substâncias e Drogas
/
Lactonas
/
Lipase
Limite:
Adulto
/
Feminino
/
Humanos
Idioma:
Coreano
Revista:
The Korean Journal of Hepatology
Ano de publicação:
2002
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS